Clinical trials are running at the slow pace in recent times. The success rate of these medical trials is experiencing a down fall. Can you expect the reason behind this? Though it comes to your surprise, the reason is the growing cost of research and development. Medical trials usually run for the longer period of time, so the cost invested in the trial is always heavy. As the outcome of the clinical trial is always uncertain, sponsors are not ready to invest such huge sum of money in conducting the clinical trial. Why is R&D cost in the clinical trial running so high? The long strategic path involved in the way drugs are discovered, developed and brought to market is the main reason behind this. The only solution to reduce the cost of R&D in the medical trials is to implement the adaptive clinical trial to shorten the process. Adaptive Clinical trials benefit you with the other advantages too. They increase the success rate of the clinical trials by giving the right information to phase III clinical trials and helps in enhancing the progress of the project further.
No comments:
Post a Comment